Translational Development Acquisition Corp. (TDAC) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Translational Development Acquisition Corp.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
28.35
Moderate
WeakModerateStrong
P/B Ratio
1.03
Strong
WeakModerateStrong
Earnings Yield
3.52%
Yield Trap
WeakModerateStrong
Profitability Health
2025Return on Equity
3.63%
Weak
WeakModerateStrong
Operating Margin
-
No data
Net Profit Margin
-
No data
Growth Indicators
2025Revenue Growth
-100.00%
Weak
WeakModerateStrong
Net Income Growth
9059.65%
Strong
WeakModerateStrong
EPS Growth
2383.95%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
0.07
Weak
WeakModerateStrong
Quick Ratio
0.07
Weak
WeakModerateStrong
Asset Turnover
-
No data
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-0.34%
Weak
WeakModerateStrong
EV / Free Cash Flow
-297.71x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.18x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
-6.736
Weak
WeakModerateStrong
Return on Invested Capital
-0.52%
Weak
WeakModerateStrong
Cash Conversion Cycle
0.00 days
Strong
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for TDAC.
View Financial Statements